Department of Research, Craniomed Group Facility SRL, 83038 Montemiletto, Italy.
Department of Radiology, Moscati Hospital, Contrada Amoretta, 83100 Avellino, Italy.
Medicina (Kaunas). 2022 May 6;58(5):642. doi: 10.3390/medicina58050642.
This short communication describes the reinfection after nearly 18 months of the same patient who was previously infected with coronavirus disease 2019 (COVID-19) and who showed multiple negative real-time quantitative reverse transcriptase-polymerase chain reaction (RT-qPCR) results by nasal swabs for severe acute respiratory syndrome coronavirus (SARS-CoV-2) but positive results on a fecal sample. We previously noted how, in the presence of symptoms suggestive of pneumonia, visible on a chest computed tomography (CT) scan and confirmed by fecal molecular testing, it was possible to draw the diagnosis of SARS-CoV-2 infection. One year later, the same patient was again affected by SARS-CoV-2. This time, the first antigenic nasal swab showed readily positive results. However, the patient's clinical course appeared to be more attenuated, showing no signs of pulmonary involvement in the radiographic examinations performed. This case shows a novelty in the pulmonary radiological evaluation of new SARS-CoV-2 infection.
这篇简短的交流文章描述了一位患者在感染 COVID-19 近 18 个月后的再次感染。该患者此前曾通过鼻拭子多次检测到严重急性呼吸综合征冠状病毒(SARS-CoV-2)的实时定量逆转录-聚合酶链反应(RT-qPCR)结果为阴性,但粪便样本结果为阳性。我们之前曾指出,在出现肺炎症状、胸部计算机断层扫描(CT)扫描可见并通过粪便分子检测确认的情况下,如何能够诊断为 SARS-CoV-2 感染。一年后,同一患者再次感染 SARS-CoV-2。这一次,第一次抗原性鼻拭子检测结果呈阳性。然而,患者的临床病程似乎有所减轻,在进行的影像学检查中没有发现肺部受累的迹象。本病例在 SARS-CoV-2 新感染的肺部影像学评估方面显示出新颖性。